Does treatment of psoriasis reduce the risk of cardiovascular disease? - Wikidata - wikimedia - TriplyDB

Does treatment of psoriasis reduce the risk of cardiovascular disease?

Does treatment of psoriasis reduce the risk of cardiovascular disease?

http://www.wikidata.org/entity/Q38178202

about

Antipsoriatic treatment extends beyond the skin: recovering of high-density lipoprotein function The Association between Psoriasis Area and Severity Index and Cardiovascular Risk Factor in Korean Psoriasis Patients Carotid intima-media thickness in patients with mild or moderate psoriasis.The effect of tumour necrosis factor inhibitor therapy on the incidence of myocardial infarction in patients with psoriasis: A retrospective study.Impact of Elevated Serum Uric Acid Levels on Systemic Inflammation in Patients With Psoriasis.Psoriasis and Cardiovascular Comorbidities: Focusing on Severe Vascular Events, Cardiovascular Risk Factors and Implications for Treatment.

P2860

Q36681220-9271BAC6-0FA7-4676-99B3-B96535A18768 Q36946016-4F5BF35B-750E-4455-B4C6-EDAAAEA1D645 Q37215912-D1BBE352-ED81-4060-8AE1-EF4CD9FEE322 Q39158398-FF0459A3-D716-4D17-AD7A-0D3958B3E8F5 Q39613176-CFCB8FCA-B7D9-4CC6-B51F-AE1F33CA350F Q46180528-AEA2BCD3-0945-44B7-8986-19EA244264E4

P2860

Does treatment of psoriasis reduce the risk of cardiovascular disease?

http://www.wikidata.org/entity/Q38178202

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Does treatment of psoriasis reduce the risk of cardiovascular disease?

@en

type

label

Does treatment of psoriasis reduce the risk of cardiovascular disease?

@en

prefLabel

Does treatment of psoriasis reduce the risk of cardiovascular disease?

@en

P1433

Q38178202-FE65601C-39BB-4B16-946E-2E96BE5D6499

P1476

Q38178202-B8C28DE1-DED8-4EBB-B47F-0E92E92E2F81

P2093

Q38178202-0ADAB187-0F6B-4100-BBA9-C82F66540E4C

Q38178202-6E3EA02E-A01C-48F2-A7D0-268480D9FAAC

Q38178202-9C8FCF6C-A617-4EF7-9B14-E0F4A785AB21

Q38178202-E3CAF93E-5061-49B4-AE72-531D07CFB7D7

P2860

Q38178202-004C8032-C526-48F6-BFA1-C6D9FDE27D59

Q38178202-03A250B2-393A-44E1-A620-2B0CC7026E6D

Q38178202-0CBDF61E-E175-4F7E-A0D4-2D1C66BB531B

Q38178202-1054D08E-8652-4093-A0B2-C0A9580B6ECC

Q38178202-14B597C6-EAB0-4EC1-82D8-D383470FAEED

Q38178202-19DA1984-3E52-4987-B9A8-E9C600771C2C

Q38178202-202E6D7C-11ED-4C95-BF8E-B5C8F75A0161

Q38178202-20583ACC-D3A1-4944-A7E2-1B5B64051517

Q38178202-20F16D38-D465-4FD7-B4A1-6071A9F7ED6D

Q38178202-20FC121F-1D17-44E8-A636-800CA3E4DADB

P2888

Q38178202-019C9640-CB0C-47D3-B44A-CBF5A0DB1294

P304

Q38178202-9DED0CC2-7DE8-4382-A213-C11FB16BB8B2

P31

Q38178202-CEA680C8-13F6-4EE5-A424-1BC5102BE7E1

P356

Q38178202-29DB8FB2-C7CE-495B-A9FD-33A48AA7459A

P433

Q38178202-5FD2C434-A7FC-4402-B868-78DFAB342977

P478

Q38178202-09C980B6-2775-40B0-8175-E4C01284D58D

P577

Q38178202-164CE661-0EDE-4B2C-9765-9AE720541D6D

P6179

Q38178202-6CE7C24B-D620-4426-B9D6-773C5700F18B

P698

Q38178202-35D34476-E921-4097-BBDA-31183AA405D0

P356

S40265-013-0173-5

P1433

P1476

Does treatment of psoriasis reduce the risk of cardiovascular disease?

@en

P2093

Liza Brown

http://www.w3.org/2001/XMLSchema#string

Neil J Korman

http://www.w3.org/2001/XMLSchema#string

Sarah Churton

http://www.w3.org/2001/XMLSchema#string

Thuzar M Shin

http://www.w3.org/2001/XMLSchema#string

P2860

Therapeutic approach in the improvement of endothelial dysfunction: the current state of the art

The risk of stroke in patients with psoriasis

Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men.

Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database.

Re-evaluation of the risk for major adverse cardiovascular events in patients treated with anti-IL-12/23 biological agents for chronic plaque psoriasis: a meta-analysis of randomized controlled trials.

Anti-psoriatic therapy recovers high-density lipoprotein composition and function.

Prevalence and treatment of psoriasis in the United Kingdom: a population-based study.

Effect of climate therapy at Gran Canaria on vitamin D production, blood glucose and lipids in patients with psoriasis.

Prevalence of the metabolic syndrome in psoriasis: results from the National Health and Nutrition Examination Survey, 2003-2006.

Systemic and vascular inflammation in patients with moderate to severe psoriasis as measured by [18F]-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT): a pilot study

P2888

s40265-013-0173-5

P304

169-182

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40265-013-0173-5

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

74

http://www.w3.org/2001/XMLSchema#string

P577

2014-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1032628371

http://www.w3.org/2001/XMLSchema#string

P698

24420963

http://www.w3.org/2001/XMLSchema#string